# A Prospective Interventional Study on the Beneficial Effect of Fish Oil-Enriched High-Protein Oral Nutritional Supplement (FOHP-ONS) on Malnourished Older Cancer Patients

**Authors:** Hui-Fang Chiu, Shu Ru Zhuang, You-Cheng Shen, Subramanian Thangaleela, Chin-Kun Wang

PMC · DOI: 10.3390/nu17152433 · Nutrients · 2025-07-25

## TL;DR

A study found that a fish oil-enriched high-protein supplement improved nutrition, strength, and quality of life in malnourished older cancer patients.

## Contribution

Demonstrates the effectiveness of a fish oil-enriched high-protein supplement in improving outcomes for malnourished cancer patients.

## Key findings

- Energy and protein intake increased significantly in patients receiving FOHP-ONS.
- Fatigue scores and quality of life improved significantly after 8 weeks of supplementation.
- Serum albumin levels increased while triglycerides and fasting blood glucose decreased.

## Abstract

Background: Malnutrition and cancer-related fatigue (CRF) are prevalent in cancer patients, significantly impacting prognosis and quality of life. Oral nutritional supplements (ONSs) enriched with protein and ω-3 fatty acids may improve nutritional status and mitigate CRF. This study evaluates the effects of a high-protein, fish oil-enriched ONS (FOHP-ONS) on nutritional intake, body composition, fatigue, and quality of life in malnourished cancer patients. Methods: Cancer patients with malnutrition or inadequate food intake received 8 weeks of FOHP-ONS (2 cans/day, providing 4.2 g/day of ω-3 fatty acids). Dietary intake, body weight, handgrip strength, serum biochemical markers, nutritional status (PG-SGA), fatigue (BFI-T), and quality of life (EORTC QLQ-C30) were assessed at baseline, week 4, and week 8. Results: Of the 33 enrolled patients, 30 completed the study. Energy and protein intake significantly increased (p < 0.05), and body BMI and handgrip strength showed significant improvements (p < 0.05), while muscle mass did not change significantly. Nutritional status, assessed by PG-SGA, improved, with the proportion of severely malnourished patients (Stage C) decreasing from 46.7% to 13.3%, and moderately malnourished patients (Stage B) improving to well-nourished status (Stage A) from 10.0% to 30.0% (p < 0.001). Serum albumin levels increased significantly (p < 0.05), while fasting blood glucose significantly decreased (p < 0.05). Additionally, triglyceride levels significantly decreased (p < 0.05), while total cholesterol and LDL-C showed a downward trend. Cancer-related fatigue scores improved across all domains (p < 0.05), and quality of life significantly increased, particularly in physical and role functioning (p < 0.05). Conclusions: FOHP-ONS supplementation improved nutritional intake, body composition, and muscle strength while alleviating CRF and enhancing quality of life in malnourished cancer patients. These findings support its potential role in nutritional intervention for malnourished cancer patients.

## Linked entities

- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}
- **Diseases:** Malnourished (MESH:D044342), fatigue (MESH:D005221), CRF (MESH:D009369)
- **Chemicals:** Fish Oil (MESH:D005395), cholesterol (MESH:D002784), omega-3 fatty acids (MESH:D015525), FOHP (-), glucose (MESH:D005947), triglyceride (MESH:D014280)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12348873/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12348873/full.md

## References

57 references — full list in the complete paper: https://tomesphere.com/paper/PMC12348873/full.md

---
Source: https://tomesphere.com/paper/PMC12348873